Frauke Schimmöller

Title: Frauke Schimmöller: Innovator in Alzheimer's Disease Research

Introduction

Frauke Schimmöller is a notable inventor based in Menlo Park, CA. She has made significant contributions to the field of neuroscience, particularly in the context of Alzheimer's disease. Her innovative work focuses on the modulation of Aβ levels, which is crucial for developing potential treatments for neurological disorders.

Latest Patents

Frauke Schimmöller holds a patent titled "Modulation of Aβ levels by β-secretase BACE2." This invention is based on the discovery that BACE 2, a homolog of β-secretase BACE, can stimulate the processing of APP in a non-amyloidogenic pathway. This process effectively suppresses the level of Aβ. The patent outlines methods and means for identifying and utilizing modulators of BACE 2's unique activity to reduce Aβ production. The compounds identified through these methods may serve as potential candidates for treating Alzheimer's disease and other neurological conditions. She has 1 patent to her name.

Career Highlights

Frauke Schimmöller has worked at Scios Inc., where she has been involved in groundbreaking research. Her work has contributed to a better understanding of the mechanisms underlying Alzheimer's disease and has opened new avenues for therapeutic interventions.

Collaborations

Frauke has collaborated with notable colleagues, including Barbara Cordell and Yu-Wang Liu. These collaborations have further enriched her research and have led to advancements in the field.

Conclusion

Frauke Schimmöller's innovative work in modulating Aβ levels represents a significant step forward in Alzheimer's disease research. Her contributions have the potential to lead to effective treatments for this challenging condition.